Method and system for controlling optical amplification in wavelength division multiplex optical transmission
    2.
    发明授权
    Method and system for controlling optical amplification in wavelength division multiplex optical transmission 失效
    用于控制波分复用光传输中的光放大的方法和系统

    公开(公告)号:US06212001B1

    公开(公告)日:2001-04-03

    申请号:US09235797

    申请日:1999-01-22

    IPC分类号: H01S300

    CPC分类号: H04J14/0221

    摘要: The present invention relates generally to the field of optical transmission and particularly to a method and a system for controlling optical amplification in wavelength division multiplex optical transmission. WDM systems currently under development will have eighty or more channels, i.e., modulated optical signals with different wavelengths (known as Dense Wavelength Division Multiplexing, DWDM). These DWDM systems are demanding optical amplifiers which, especially considering the cascadation of a plurality of optical amplifiers along the transmission path of the DWDM system, have only very limited tolerances in certain parameters. Among these parameters gain flatness and gain tilt are of special importance. The present invention discloses a method and a system which make use of auxiliary optical signals having a given power level which is equal for all auxiliary signals. Differences in the power levels of the auxiliary signals after optical amplification are used for the control of the optical amplifiers of the WDM system.

    摘要翻译: 本发明一般涉及光传输领域,特别涉及用于控制波分复用光传输中的光放大的方法和系统。 目前正在开发的WDM系统将具有八十个或更多个信道,即具有不同波长的调制光信号(称为密集波分复用,DWDM)。 这些DWDM系统要求光放大器,特别是考虑到沿着DWDM系统的传输路径的多个光放大器的级联,在某些参数中仅具有非常有限的公差。 在这些参数中,增益平坦度和增益倾斜特别重要。 本发明公开了一种使用具有与所有辅助信号相等的给定功率电平的辅助光信号的方法和系统。 光放大后辅助信号的功率电平差异用于WDM系统的光放大器的控制。

    MODULAR MEMBER AND STABLE SUPPORT BODY CONSTITUTED THEREBY
    3.
    发明申请
    MODULAR MEMBER AND STABLE SUPPORT BODY CONSTITUTED THEREBY 审中-公开
    模块化的会员和稳定的支持体

    公开(公告)号:US20160168841A1

    公开(公告)日:2016-06-16

    申请号:US15049076

    申请日:2016-02-20

    申请人: Jianhui Zhou

    IPC分类号: E04B1/19

    摘要: A combined member, comprising a communication rod (1) and a connecting rod (2), wherein the connecting rod (2) comprises a rod body (2.1) and a connector (2.2), the connector (2.2) being a fastening connector (3) or a sleeving connector (4), the rod body (2.1) of the connecting rod (2.1) and a rod body of the communication rod (1) being of a strip-shaped structure, the connecting rod (2) being connected to the communication rod (1) by the fastening connector (3) or the sleeving connector (4), the axis of the connecting rod (2) intersecting that of the communication rod (1) connected thereto. The combined member has the advantages of high bearing capacity, and convenient construction.

    摘要翻译: 一种组合构件,包括通信杆(1)和连杆(2),其中所述连杆(2)包括杆体(2.1)和连接器(2.2),所述连接器(2.2)是紧固连接器 3)或套筒连接器(4),连杆(2.1)的杆体(2.1)和连杆(1)的杆体是条形结构,连杆(2)连接 通过紧固连接器(3)或套筒连接器(4)与连杆(1)连接,连杆(2)的轴线与与其连接的连杆(1)的轴线相交。 组合件具有承载力高,施工方便的优点。

    Thermosetting coating composition
    4.
    发明授权
    Thermosetting coating composition 有权
    热固性涂料组合物

    公开(公告)号:US08969489B2

    公开(公告)日:2015-03-03

    申请号:US13205152

    申请日:2011-08-08

    摘要: The invention is a thermosetting coating composition comprised of an aliphatic polycarbonate resin and a cross linker. The aliphatic polycarbonate resins are derived from hydroxyl containing compounds including 2,2,4,4-tetramethyl-1,3-cyclobutanediol (TMCD) and 1,4-cyclohexane dimethanol (CHDM). The coatings made of these polycarbonates exhibit exceptional toughness; they possess a high degree of hardness while maintaining a high level of flexibility/impact resistance. These polycarbonate resins also exhibited better hydrolytic stability as compared to their polyester counterparts.

    摘要翻译: 本发明是由脂族聚碳酸酯树脂和交联剂组成的热固性涂料组合物。 脂肪族聚碳酸酯树脂衍生自包含2,2,4,4-四甲基-1,3-环丁二醇(TMCD)和1,4-环己烷二甲醇(CHDM)的含羟基化合物。 由这些聚碳酸酯制成的涂层表现出优异的韧性; 它们具有高度的硬度,同时保持高水平的柔韧性/抗冲击性。 与聚酯树脂相比,这些聚碳酸酯树脂也表现出更好的水解稳定性。

    Channel band conversion apparatus for optical transmission systems
    6.
    发明授权
    Channel band conversion apparatus for optical transmission systems 有权
    用于光传输系统的信道频带转换装置

    公开(公告)号:US06509987B1

    公开(公告)日:2003-01-21

    申请号:US09371165

    申请日:1999-08-10

    IPC分类号: H04J1402

    摘要: The number of optical channels that may be used to transmit information/data is greatly enhanced using an optical transmission facility having a transmitter that outputs optical signals having respective wavelengths within a first bandwidth, e.g., the C band, combines the latter signal with an optical signal having a wavelength between the first bandwidth and a second bandwidth, e.g., the L-band, and, using a non-linear frequency converter, processes the combined signal to form at least optical signals having wavelengths within the second bandwidth that correspond with the wavelengths of the optical signals within the first bandwidth. In this way, equipment designed for the C band may also be used to process optical signals with another, second band.

    摘要翻译: 使用具有输出具有第一带宽内的各个波长的光信号的发射机的光传输设备,例如C波段,将后一信号与光信号相结合,可以大大增强可用于传输信息/数据的光信道数量 具有第一带宽和第二带宽之间的波长的信号,例如L波段,并且使用非线性频率转换器处理组合信号,以至少形成具有与第二带宽内的波长相对应的波长的光信号 在第一带宽内的光信号的波长。 以这种方式,为C频带设计的设备也可以用于处理具有另一个第二频带的光信号。

    Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
    7.
    发明授权
    Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor 有权
    鞘氨醇-1-磷酸裂解酶多肽,多核苷酸和调节剂及其用途的方法

    公开(公告)号:US07973143B2

    公开(公告)日:2011-07-05

    申请号:US12341520

    申请日:2008-12-22

    摘要: Compositions, methods and kits for diagnosing and treating cancer are provided. Therapeutic compositions may comprise agents that modulate the expression or activity of a sphingosine-1-phosphate lyase (SPL). Such compositions may be administered to a mammal afflicted with cancer. Diagnostic methods and kits may employ an agent suitable for detecting alterations in endogenous SPL. Such methods and kits may be used to detect the presence of a cancer or to evaluate the prognosis of a known disease. SPL polypeptides, polynucleotides and antibodies are also provided.

    摘要翻译: 提供用于诊断和治疗癌症的组合物,方法和试剂盒。 治疗组合物可以包含调节鞘氨醇-1-磷酸裂解酶(SPL)的表达或活性的试剂。 这种组合物可以施用于患有癌症的哺乳动物。 诊断方法和试剂盒可以使用适合于检测内源性SPL变化的试剂。 这些方法和试剂盒可用于检测癌症的存在或评价已知疾病的预后。 还提供了SPL多肽,多核苷酸和抗体。

    Intelligent optical systems and methods for optical-layer management
    8.
    发明授权
    Intelligent optical systems and methods for optical-layer management 有权
    智能光学系统和光层管理方法

    公开(公告)号:US07933518B2

    公开(公告)日:2011-04-26

    申请号:US12035327

    申请日:2008-02-21

    IPC分类号: H04B10/08

    CPC分类号: H04B10/40

    摘要: An integrated optical transceiver includes an optical receiver that produces a first electrical signal at a reception electrical interface in response to a first optical signal, an optical transmitter that emits a second optical signal in response to a second electrical signal received at a transmission electrical interface, a first optical branching device that receives the first optical signal at an reception optical interface and to direct at least a portion of the first optical signal to the optical receiver, and a second optical branching device that directs the second optical signal to an transmission optical interface. The first optical branching device directs at least a portion of the first optical signal to the second optical branching device. The second optical branching device directs the portion of the first optical signal received from the first optical branching device to the transmission optical interface.

    摘要翻译: 集成光收发器包括:光接收器,其响应于第一光信号在接收电接口处产生第一电信号;响应于在传输电接口接收的第二电信号发射第二光信号的光发射机, 第一光分支装置,其在接收光接口处接收所述第一光信号并将所述第一光信号的至少一部分引导到所述光接收器;以及第二光分支装置,其将所述第二光信号引导到透射光接口 。 第一光分路装置将第一光信号的至少一部分引导到第二光分支装置。 第二光分支装置将从第一光分支装置接收的第一光信号的部分引导到传输光接口。

    SMART OPTICAL TRANSCEIVER HAVING INTEGRATED OPTICAL DYING GASP FUNCTION
    9.
    发明申请
    SMART OPTICAL TRANSCEIVER HAVING INTEGRATED OPTICAL DYING GASP FUNCTION 有权
    具有集成光学吸收功能的智能光收发器

    公开(公告)号:US20100215359A1

    公开(公告)日:2010-08-26

    申请号:US12390484

    申请日:2009-02-22

    IPC分类号: H04B10/08 H04B10/06 H04B10/00

    CPC分类号: H04B10/40

    摘要: An optical transceiver includes an electric terminal that can receive power from a host equipment and provide a power supply voltage to the optical transceiver, and a power failure monitor circuit that can detect an imminent loss of the power supply voltage. The power failure monitor circuit can produce a dying-gasp control signal when such imminent loss of power supply voltage is detected or when a disabling control signal is received from the host equipment. A driver can receive the dying-gasp control signal. An optical transmitter is powered by the power supply voltage and can emit a first optical signal under the control of the driver. The driver can modulate an envelope of the first optical signal in response to the dying-gasp control signal to produce a modulated envelope comprising a first dying gasp signal.

    摘要翻译: 光收发器包括能够从主机设备接收电力并向光收发器提供电源电压的电端子,以及能够检测即将发生的电源电压损失的电源故障监视电路。 当检测到电源电压即将发生或当从主机设备接收到禁用控制信号时,电源故障监控电路可以产生一个垂死的喘气控制信号。 驾驶员可以接收垂直喘气控制信号。 光发射机由电源电压供电,并可在驱动器的控制下发出第一光信号。 驱动器可以响应于垂直气体控制信号来调制第一光信号的包络,以产生包括第一垂直气体信号的调制包络。

    SPHINGOSINE-1-PHOSPHATE LYASE POLYPEPTIDES, POLYNUCLEOTIDES AND MODULATING AGENTS AND METHODS OF USE THEREFOR
    10.
    发明申请
    SPHINGOSINE-1-PHOSPHATE LYASE POLYPEPTIDES, POLYNUCLEOTIDES AND MODULATING AGENTS AND METHODS OF USE THEREFOR 有权
    磷脂酸1-磷酸盐多糖,多核苷酸和调节剂及其使用方法

    公开(公告)号:US20090203044A1

    公开(公告)日:2009-08-13

    申请号:US12341520

    申请日:2008-12-22

    IPC分类号: G01N33/573 C07K16/18

    摘要: Compositions, methods and kits for diagnosing and treating cancer are provided. Therapeutic compositions may comprise agents that modulate the expression or activity of a sphingosine-1-phosphate lyase (SPL). Such compositions may be administered to a mammal afflicted with cancer. Diagnostic methods and kits may employ an agent suitable for detecting alterations in endogenous SPL. Such methods and kits may be used to detect the presence of a cancer or to evaluate the prognosis of a known disease. SPL polypeptides, polynucleotides and antibodies are also provided.

    摘要翻译: 提供用于诊断和治疗癌症的组合物,方法和试剂盒。 治疗组合物可以包含调节鞘氨醇-1-磷酸裂解酶(SPL)的表达或活性的试剂。 这种组合物可以施用于患有癌症的哺乳动物。 诊断方法和试剂盒可以使用适合于检测内源性SPL变化的试剂。 这些方法和试剂盒可用于检测癌症的存在或评价已知疾病的预后。 还提供了SPL多肽,多核苷酸和抗体。